Northstar Emergency Management, LLC
Small business focused on development of antibody-fragment-based biodefense countermeasures intended for rapid point-of-incident diagnosis and treatment. The organization pursues partnerships for antibody design, testing, and scaled production and engages with government and research stakeholders on program development.
Industries
N/A
Products
Antibody fragment-based point-of-incident countermeasure (concept)
A concept for using engineered antibody fragments as on-site diagnostics and therapeutics intended to provide rapid diagnosis and immediate treatment in bioterrorism or biodefense events.
Antibody fragment-based point-of-incident countermeasure (concept)
A concept for using engineered antibody fragments as on-site diagnostics and therapeutics intended to provide rapid diagnosis and immediate treatment in bioterrorism or biodefense events.
Services
Partnerships for antibody design, testing, and scaled production
Collaborative partnerships and coordination with external organizations for antibody design, testing workflows, and planning for scaled biologics production.
Partnerships for antibody design, testing, and scaled production
Collaborative partnerships and coordination with external organizations for antibody design, testing workflows, and planning for scaled biologics production.
Expertise Areas
- Biodefense and bioterrorism countermeasure development
- Antibody fragment engineering
- Rapid point-of-incident diagnostics and therapeutic concepts
- Partnership development and collaboration management
Key Technologies
- Antibody fragment (Fab) engineering
- Point-of-care / point-of-incident diagnostic concepts
- Rapid therapeutic deployment using antibody fragments
- Biologics scale-up planning